University of Wollongong’s 3D Bioprinter Could Improve Type 1 Diabetes Treatment

Published by , December 12, 2017 12:42 pm

( Australia’s University of Wollongong (UOW) is quickly becoming a pioneer in 3D bioprinting technologies. Recently, the university unveiled a new customized 3D bioprinter which has the potential to drastically improve treatment for patients with Type 1 diabetes.
According to the UOW, the 3D bioprinter is capable of depositing a special bioink (which contains insulin-producing islet cells) into a transplantable 3D printed scaffold structure. This method could improve on the existing process of implanting islet cells from human donors to treat serious Type 1 diabetes cases because it can reportedly decrease the risk of cell rejection in the recipient’s body.

Tags: , ,